EmiHCaywoodMDFACP
Pediatric Hematology & Oncology • Wilmington, DENemours-AIDHC Blood and Bone Marrow Transplant, Hematology/Oncology
Dr. Caywood is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1600 Rockland Road
Wilmington, DE 19803Phone+1 302-651-4200Fax+1 302-651-5510
Summary
- Dr. Emi Caywood is a pediatric hematologist/oncologist in Wilmington, DE and is affiliated with multiple hospitals in the area, including Thomas Jefferson University Hospitals, Alfred I. duPont Hospital for Children, and Nemours Children's Hospital. She received her medical degree from Rutgers Robert Wood Johnson Medical School and has been in practice 15 years. She is experienced in myeloid leukemia and pediatric bone marrow transplantation.
Education & Training
Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 2005 - 2008
MedStar Health/Georgetown University HospitalResidency, Pediatrics, 2002 - 2005
Rutgers Robert Wood Johnson Medical SchoolClass of 2002
Certifications & Licensure
DE State Medical License Active through 2025
PA State Medical License Active through 2024
MD State Medical License 2005 - 2010
DC State Medical License 2004 - 2005
VA State Medical License 2002 - 2005- American Board of Pediatrics Pediatric Hematology-Oncology
- American Board of PediatricsHematology/Oncology
Clinical Trials
- Metformin in Children With Relapsed or Refractory Solid Tumors Start of enrollment: 2012 Sep 24
- Sorafenib and Topotecan in Refractory/Recurrent Pediatric Malignancies Start of enrollment: 2013 Jan 01
- Bosutinib in Pediatric Patients With Newly Diagnosed Chronic Phase or Resistant/Intolerant Ph + Chronic Myeloid Leukemia Start of enrollment: 2020 Apr 06
Roles: Contact, Principal Investigator
- Join now to see all
Publications & Presentations
PubMed
- 50 citationsUnilateral Retinoblastoma Managed With Intravenous Chemotherapy Versus Intra-Arterial Chemotherapy. Outcomes Based on the International Classification of RetinoblastomaCarol L. Shields, Rodrigo Jorge, Emil Anthony T. Say, George Magrath, Adel E. Alset
Asia-Pacific Journal of Ophthalmology. 2016-03-01 - 109 citationsTargeted retinoblastoma management: when to use intravenous, intra-arterial, periocular, and intravitreal chemotherapyCarol L. Shields, Sara E. Lally, Ann Leahey, Pascal Jabbour, Emi Caywood
Current Opinion in Ophthalmology. 2014-09-01 - 26 citationsPrognostic factors of childhood and adolescent acute myeloid leukemia (AML) survival: evidence from four decades of US population data.Jobayer Hossain, Li Xie, Emi Caywood
Cancer Epidemiology. 2015-10-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
